| Institution: | 1. Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands;2. Department of Respiratory Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands;3. Population Pharmacogenetics Group, Biomedical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK;4. Department of Pulmonology, Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;5. Department of Paediatric Pulmonology and Paediatric Allergology, Beatrix Children's Hospital, Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;6. Department of Child Health, University of Aberdeen, Aberdeen, UK;7. Academic Department of Paediatrics, Royal Alexandra Children's Hospital, Brighton and Sussex Medical School, Brighton, UK;8. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA;9. Sainte‐ Justine University Health Center, Montreal, Quebec, Canada;10. Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK;11. Department of Biostatistics, University of Liverpool, Liverpool, UK;12. Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK;13. Department of Medicine, University of California, San Francisco, CA, USA;14. CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain;15. Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA |
